Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Video

Is my family at risk for developing BPDCN?

Posted by
HealthTree Logo HealthTree
• May 20, 2026

Description

Is BPDCN Hereditary? Familial Risks and Associated Malignancies

 

One of the most common questions newly diagnosed patients ask is, "Do my children or siblings need to be tested?" In this lesson, experts clarify that BPDCN is not typically classified as a directly inherited condition.

 

We also explore the unusual link between BPDCN and other blood cancers—such as AML, MDS, CMML, and Multiple Myeloma—and what this connection suggests about the genetic basis of these disorders.

On this video

Transcript

Is my family at risk for developing BPDCN?

This definitely comes up. And I just had a large family in my office with, a family member who has BPDCN

And the question was, do we all need to get tested? Do our kids need to get tested? And the answer is no.

There really isn't a need to test family members. I think vigilance is important. So I think everyone, but particularly maybe family members who have a family, you know, member who has a malignancy of sort should be up on their screening, whether it's, you know, yearly blood counts, colonoscopy, you know, mammogram for women.

So those things are really essential to do. But there's no beyond that. No specific testing, either molecular bone marrow biopsies that need to be done on family members.

I would say that when you have these rare diseases, we don't have any screening to identify beforehand, but I think you ask a really great question.

One is, are we seeing families of patients with multiple, you know, members with BPDCN, maybe not BPDCN in particular yet, you know, as it's an emerging field, but you definitely see patients where there are multiple family members, blood related with blood cancers and blood disorders, including but not limited to acute myeloid leukemia, which BPDCN used to be part of that family.

So I think that's something we need to learn more about. So that would be more towards the genetic basis. And then too an unusual component of BPDCN. As I spend my life and career researching it, is that I'm seeing maybe 20 and maybe up to 30% of patients who occur BPDCN with another prior or concomitant hematologic malignancy. It's a very unusual finding in such a rare disease to then be paired with other, if you will, more common blood cancers.

And those blood cancers are serious ones as well CMML, MDS, MPN, AML, multiple myeloma, T-ALL, just to name a few. And we've published on this before.

 

Related Content